Skip navigation

Refine by Type

Results 1 - 10 of 12 for Ibrutinib
  1. Ibrutinib is used to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins ... treated with at least one other chemotherapy medication. Ibrutinib is in a class of medications called kinase ...
  2. Lymphoma Research Foundation (Lymphoma Research Foundation)  
    ... at the LRF Annual Gala FDA Approves Imbruvica (Ibrutinib) for CLL LRF Launches LEAP Cycle for a ... at the LRF Annual Gala FDA Approves Imbruvica (Ibrutinib) for CLL LRF Launches LEAP Cycle for a ...
  3. Leukemia Trial Results From the National Institutes of Health (National Cancer Institute)  
    ... Coordinating Center for Clinical Trials Leukemia Trial Results Ibrutinib Improves Survival Compared with Ofatumumab in Patients with ... small lymphocytic lymphoma (SLL) who were treated with ibrutinib (Imbruvica®) lived longer without their disease getting worse ...
  4. Drugs Approved for Leukemia From the National Institutes of Health (National Cancer Institute)  
    ... Cyclophosphamide) Fludara (Fludarabine Phosphate) Fludarabine Phosphate Gazyva (Obinutuzumab) Ibrutinib Idelalisib Imbruvica (Ibrutinib) Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Mechlorethamine ...
  5. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Idelalisib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon Alfa- ...
  6. ... not been targeted before. One of these drugs, ibrutinib (brand name: Imbruvica), has been approved for use ... seen in the majority of patients treated with ibrutinib in trials, with dramatic responses even in heavily ...
  7. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hyper-CVAD Back to Top I Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Idelalisib Ifex (Ifosfamide) Ifosfamide Ifosfamidum (Ifosfamide) Imatinib Mesylate Imbruvica (Ibrutinib) Imiquimod Inlyta (Axitinib) Intron A (Recombinant Interferon Alfa- ...
  8. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... refractory, low-grade or follicular B-cell NHL. Ibrutinib (Imbruvica™) is an oral drug indicated for the ...
  9. Mantle Cell Lymphoma (Leukemia & Lymphoma Society) - PDF  
    ... 1101 (CAL-101) and Bruton’s tyrosine kinase inhibitor ibrutinib (PCI-32765). l Monoclonal antibodies –These agents provide ...
  10. ... also be tried. Newer drugs such as ofatumumab, ibrutinib (Imbruvica), and idelalisib (Zydelig) may be other options. ...
previous · 1 · 2 · next